Biolase Inc
(BIOLQ)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 12,154 | 10,020 | 12,634 | 10,806 | 12,612 |
| Cost of Goods | 7,846 | 6,987 | 9,020 | 7,951 | 7,908 |
| Gross Profit | 4,308 | 3,033 | 3,614 | 2,855 | 4,704 |
| Operating Expenses | 9,833 | 9,204 | 8,355 | 8,567 | 10,092 |
| Operating Income | -4,679 | -5,184 | -4,721 | -4,761 | -4,480 |
| Interest Expense | 35 | 12 | 0 | -10 | 0 |
| Other Income | -187 | 207 | 186 | 174 | 227 |
| Pre-tax Income | -4,901 | -4,989 | -4,535 | -4,577 | -4,253 |
| Income Tax | 10 | 32 | -693 | 35 | 36 |
| Net Income Continuous | -4,911 | -5,021 | -3,842 | -4,612 | -4,289 |
| Net Income | $-4,911 | $-5,021 | $-3,842 | $-4,612 | $-4,289 |
| EPS Basic Total Ops | -600.00 | -625.00 | -500.00 | -750.00 | -1,525.00 |
| EPS Basic Continuous Ops | -597.79 | -613.24 | -546.52 | -758.70 | -790.69 |
| EPS Diluted Total Ops | -600.00 | -625.00 | -500.00 | -750.00 | -1,525.00 |
| EPS Diluted Continuous Ops | -597.79 | -613.24 | -546.52 | -758.70 | -790.69 |
| EBITDA(a) | $-4,399 | $-4,913 | $-4,405 | $-4,451 | $-4,193 |